cardiovascular diseases therapeutics in major developed markets to 2019: increasing prevalence and...
TRANSCRIPT
www.MarketResearchReports.com
Cardiovascular Diseases
Therapeutics in Major Developed Markets to 2019 -
Increasing Prevalence and
Promising Novel Drugs offset Patent
Cliff ThreatCategory : Diseases / Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: November 30, 2013
Number of Pages: 106
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
The global market for Cardiovascular Disease (CVD) - comprised of Heart Failure (HF), Myocardial Infarction and Acute Coronary Syndrome (ACS) - is expected to grow at a moderate rate, from $13.7 billion in 2012 to $18.2 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 4.1%.
www.MarketResearchReports.com
Research Findings
The latest report states that out of the eight major markets (the US, France, Germany, Italy, Spain, UK, Japan and Canada), the US will boast the largest value, from $6.1 billion in 2012 to $8.49 billion by 2019, at a higher CAGR of 4.7%.
This growth is partially due to the increase of the treatment population, which is forecast to jump from 14 million in 2012 to 16 million by 2019, at a CAGR of 1.6%.New drugs are also expected to have a positive impact upon the CVD market, including LCZ696 and Serelaxin by Novartis, AZD6140 by AstraZeneca and BAY81-8781 by Bayer.
However, the CVD market is hampered by high costs, with the annual cost of treatment for the three CVD indications estimated to increase from $4,214 in 2012 to $4,876 by 2019, at a CAGR of 2.1%.
www.MarketResearchReports.com
Scope
Disease overview and treatment usage patterns
Market size and forecast for heart failure, Myocardial Infarction (MI) and Acute Coronary Syndrome (ACS)
Geographic coverage includes the top eight markets (the US, the UK, Germany, France, Italy, Spain, Japan and Canada) from 2012 to 2019
Major marketed products for the indications types covered
In-depth pipeline analysis for heart failure, MI and ACS
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Key licensing and co-development agreements in the cardiovascular market
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Therapeutic Landscape
3. Marketed Products
4. Pipeline Analysis
5. Cardiovascular Diseases Global Market to 2019, Market Forecast
6. Deals and Strategic Consolidations
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://www.marketresearchreports.com/gbi-research/cardiovascular-diseases-therapeutics-major-developed-markets-2019-increasing-prevalence
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)